Consensus diagnosis and therapy of soft tissue sarcoma

被引:10
作者
Brodowicz, Thomas [1 ]
Amann, Gabriele [2 ]
Leithner, Andreas [3 ]
Sztankay, Arpad [4 ]
Kainberger, Franz [5 ]
Eisterer, Wolfgang [6 ]
Liegl-Atzwanger, Bernadette [7 ]
Rachbauer, Franz [8 ]
Rath, Thomas [9 ]
Bergmann, Michael [10 ]
Funovics, Philipp T. [12 ]
Ploner, Ferdinand [11 ]
Windhager, Reinhard [12 ]
机构
[1] Univ Klin Innere Med, Klin Abt Onkol, Vienna, Austria
[2] Med Univ Wien, Klin Inst Pathol, Vienna, Austria
[3] Univ Klin Orthopadie & Orthopad Chirurg, Graz, Austria
[4] Med Univ Innsbruck, Univ Klin Shrahlentherapie Radioonkol, Innsbruck, Austria
[5] Univ Klin Radiodiagnost, Abt Neuro & Muskuloskeletale Radiol, Vienna, Austria
[6] Univ Klin Innere Med I, Innsbruck, Austria
[7] Med Univ Graz, Inst Pathol, Graz, Austria
[8] Univ Klin Orthopadie, Innsbruck, Austria
[9] Univ Klin Chirurg, Klin Abt Wiederherstellungs & Plast Chirurg, Vienna, Austria
[10] Med Univ Wien, Abt Allgemeinchirurg, Vienna, Austria
[11] Univ Klin Innere Med, Klin Abt Onkol, Graz, Austria
[12] Univ Klin Orthopadie, Vienna, Austria
关键词
Soft tissue sarcoma; consensus; Austria; multimodality treatment; guidelines; RANDOMIZED PHASE-II; RADIATION-THERAPY; EUROPEAN-ORGANIZATION; PROGNOSTIC-FACTORS; NEOADJUVANT CHEMOTHERAPY; HIGH-RISK; INTRAOPERATIVE BRACHYTHERAPY; POSTOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; BEAM RADIOTHERAPY;
D O I
10.1007/s00508-011-0079-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Soft tissue sarcomas are heterogeneous tumours and relatively uncommon. There have been advances over the past years concerning pathology, clinical behaviour, diagnosis strategies and the treatment. To summarize these advances as well as making it public is one of the goals of the following consensus guidelines. But why do we need special guidelines for Austria? There are international guidelines published by the European Society of Medical Oncology (ESMO) and the National Comprehensive Cancer Network (NCCN). The cause is that we need an explanation of the matrix the ESMO and the NCCN gave according to our clinical practice, the local requirements and facilities in Austria. The following recommendations were drawn up following a consensus meeting of sarcoma specialists from the three high volume centres located at the medical universities in Austria. All fields of involved physicians from diagnosis to therapy worked together to know that soft tissue sarcomas are an interdisciplinary challenge and multimodal treatment is essential. For this reason, these guidelines not only explain but also give the state of the art and clear recommendations. One of the most important guidelines is that any patient with a suspected soft tissue sarcoma should be referred to one of the three university centres and managed by a specialist sarcoma multidisciplinary team. We hope that the consensus is helpful for the clinical practice and improves the quality of care for patients with soft tissue sarcomas in Austria.
引用
收藏
页码:85 / 99
页数:15
相关论文
共 50 条
  • [21] Can we predict the response to therapy in soft tissue sarcoma?
    File, Danielle
    Grilley-Olson, Juneko E.
    FUTURE ONCOLOGY, 2018, 14 (02) : 101 - 104
  • [22] Systemic Therapy for Advanced Soft Tissue Sarcoma
    Sheng, Jennifer Y.
    Mowa, Sujana
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (05) : 1141 - +
  • [23] Target volume in soft tissue sarcoma of the extremities
    Faivre, J. -C.
    Le Pechoux, C.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 444 - 452
  • [24] Team Approach: Extremity Soft Tissue Sarcoma
    Morris, Carol D.
    Banks, Lauren B.
    Fitzhugh, Valerie A.
    McGill, Kevin C.
    Deville, Curtiland
    JBJS REVIEWS, 2023, 11 (12)
  • [25] Local Recurrence of Extremity Soft Tissue Sarcoma
    Guerrero, Whitney M.
    Deneve, Jeremiah L.
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (05) : 1157 - +
  • [26] Preoperative Therapy for Extremity Soft Tissue Sarcomas
    Davis, Lara E.
    Ryan, Christopher W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (06)
  • [27] Radiotherapy of soft tissue sarcoma
    Boelke, E.
    Orth, K.
    Peiper, M.
    Eisenberger, C. F.
    Matuschek, C.
    Gerber, P. A.
    Fenk, R.
    Engers, R.
    Gripp, S.
    Budach, W.
    ONKOLOGE, 2009, 15 (04): : 398 - 403
  • [28] Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult
    Gronchi, Alessandro
    Casali, Paolo G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (03) : 415 - 424
  • [29] Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?
    Noebauer-Huhmann, I. -M.
    Grieser, T.
    RADIOLOGE, 2017, 57 (11): : 923 - 937
  • [30] Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma
    Kawaguchi, Kuniki
    Nakano, Kenji
    Urasaki, Tetsuya
    Fukuda, Naoki
    Taira, Shinichiro
    Ono, Makiko
    Tomomatsu, Junichi
    Nishizawa, Masatoshi
    Ae, Keisuke
    Matsumoto, Seiichi
    Takahashi, Shunji
    IN VIVO, 2019, 33 (05): : 1609 - 1614